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Myung-Sun Kim, Jiyeon Yoo 
Objective: Alcohol affects  functions of prefrontal and temporal 
cortices, and alcohol use disorder and binge drinking share 
structural/functional abnormalities and cognitive deficits. This study 
investigated the neuropsychological profile of college students with 
binge drinking. 
Participants and Methods: Participants: Based on  the scores of 
Alcohol Use Disorder Identification Test (AUDIT) and Alcohol Use 
Questionnaire (AUQ), binge-drinking (n>=32, male: 8, female: 24) 
and control (n=32, male: 8, female: 24) groups were determined. 
Neuropsychological tests:  The Rey-Osterrieth Complex Test 
(RCFT), California Verbal Learning Test (CVLT), Wisconsin Card 
Sorting Test and Stroop Test were administered to evaluate 
nonverbal memory, verbal memory, executive function and attention, 
respectively.  
Statistical analysis: Scores of the AUDIT and AUQ were analyzed by 
one-way ANOVA, and the performances on the neuropsychological 
tests were analyzed by multivariate ANOVA. 
Results: The binge-drinking and control groups differed on AUDIT 
(F(1,63) = 538.29, p < .001) and AUQ (F(1,63) = 97.34, p < .001), 
with binge-drinking group obtaining significantly higher scores 
compared to the control group. The two groups differed on the copy 
(F(1,62) = 6.05, p < .05), immediate recall (F(1,62) = 11.68, p <.01) 
and delayed recall (F(1,62) = 11.87, p <.01) of the RCFT, and the 
long-term free recall of the CVLT (F(1,62) = 13.37, p < .01). The 
binge-drinking group exhibited significantly lower scores than did 
control group. 
Conclusions: College students with binge drinking showed 
difficulties with verbal and nonverbal memory, and the present results 
indicate that excessive drinking could affect memory even when 
drinking history is relatively short. 
Correspondence: Myung-Sun Kim, Sungshin Women's University, 
kimms@sungshin.ac.kr 
 
Measuring illness insight in patients with alcohol-related 
cognitive dysfunctions using the Q8 questionnaire: A validation 
study 
Serge Walvoort, Paul Van der Heijden, Roy Kessels, Jos Egger 
Objective: One consequence of alcohol-related cognitive 
dysfunction is impaired illness insight, which may hamper treatment 
outcome. That is, patients typically underestimate the amount of 
alcohol they have used, underestimate the length of their alcohol 
addiction, and misjudge the severe and adverse consequences of 
alcohol addiction on daily life and health functioning. In this study, we 
validated the Q8, a short questionnaire for the assessment of illness 
insight, in patients with Korsakoff’s syndrome (KS) and alcoholic 
controls. 
Participants and Methods: Ninety-seven patients alcohol use 
disorder (AUD) patients completed the Q8 as part of their regular 
assessment procedure. Forty-two were diagnosed as KS patients (29 
men; mean age=57.4; range 42-77), fifty-five as alcoholic controls 
(38 men; mean age=54.7; range 30-76). The Q8 was validated by 
comparing it to the Dysexecutive Questionnaire (DEX) and relating it 
to tests for processing speed, memory and executive function. 
Internal consistency of the Q8 and correlations between the DEX and 
the neuropsychological measures were computed.  
Results: Internal consistency of the Q8 was acceptable (Cronbach’s 
alpha=0.73) and significant correlations between Q8 and the DEX 
questionnaire and the neuropsychological measures were found (r-
values>.26, p< 0.05), indicating that a higher degree of illness insight 
is associated with more self-reported cognitive complaints and better 
cognitive functioning. 
Conclusions: The Q8 is a short, valid and easy to administer 
questionnaire for assessing illness insight in patients with moderate 
and severe alcohol-related cognitive dysfunction. 
Correspondence: Serge Walvoort, Vincent van Gogh Institute for 
Psychiatry, swalvoort@vvgi.nl 
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Inflammation and cardiovascular biomarkers are associated 
with cognitive performance in HIV patients. Combination 
antiretroviral therapy restores CD4+ cell counts and supresses 
viral replication. However, immune activation and inflammation 
may persist 
Berta Torres, Silvia Cañizares, Agathe León, Montserrat Plana, 
Llucia Alós, Mattia Squarcia, Miguel Caballero, Xavier Filella, Carlos 
Reverter, Naira Rico, Esteban Martínez, Jordi Blanch, Araceli 
Roussaud, Felipe García-Alcalde 
Objective: The aim of this work was to examine if some cognitive 
functions in HIV-infected patients were related to some inflammation 
and cardiovascular biomarkers. 
Participants and Methods: 12 volunteers, who were part of a larger 
longitudinal study, were recruited from the Hospital Clinic of 
Barcelona (Spain).  Selected patients were on cART 
(EFV/FTC/TDF), viral load < 37 copies, CD4+ >250 cel/mm3 and 
without any significant coinfection. 
Data examined here are cross-sectional and obtained in the baseline 
measurement. Participants underwent comprehensive neurocognitive 
and medical evaluations. The neuropsychological assessment 
comprised executive functions, speed of cognitive processing, motor 
speed, and learning and memory. Inflammation was evaluated by 
determination of plasma IL-6 and TNF-α. D-dimer was used as a 
marker of cardiovascular disease. A correlational analysis was 
performed. Bonferroni's correction was applied to comparisons. 
Results: IL6 was positively related with cognitive slowing. D-dimer 
was positively associated with cognitive and psychomotor slowing, 
and inversely with verbal learning. A trend was found between IL6 
and mistakes in cognitive flexibility, and also between d-dimer and 
mistakes in cognitive inhibition. However, statistical significance 
disappeared when Bonferroni's correction was applied. 
Conclusions: Data suggest that some inflammation and 
cardiovascular markers could adversely affect cognitive performance 
in HIV patients, even in patients receiving treatment in the setting of 
a chronic and stable disease and without a HAND diagnosis. Results 
should be interpreted with caution due to limitations of the study. 
Correspondence: Silvia Cañizares, Hospital Clinic of Barcelona, 
silvia.canizares@clinic.ub.es 
 
Switching to a non-Efavirenz containing regime improves 
cognition in HIV-infected patients 
M.H.M. Ensing, C.S. Hakkers, J.E. Arends, M.A.C. Emons, M.J.E. 
Van Zandvoort, A.I.M. Hoepelman 
Objective: HAND is a frequent comorbidity in HIV-infected patients. 
The aim of this study is to assess the effect of switching Atripla (a 
regimen containing Efavirenz which is known for its adverse 
neurological of psychiatric events), to Eviplera (same as Atripla, 
without Efavirenz) on cognition, hypothesizing participants' cognition 
will improve on Eviplera. 
Participants and Methods: Participants N=48[32:16] were 
virologically suppressed male HIV-infected patients aged 25-50 on 
Atripla, without neurocognitive complaints. They were randomized 
(2:1) to receive Eviplera (intervention group) or continue on Atripla 
(control group) both for 12 weeks. At baseline and week 12, patients 
underwent neuropsychological testing, assessing the following 
domains; conceptual organization, executive functioning, speed of 
information processing, learning, memory, attention and working 
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